Bio-Rad Laboratories BIO
NYSE BIO
$376.41 +12.15 (+3.34%)
As of: Aug 20, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Gross Margin Growth (1y) (2010 - 2026)

Bio-Rad Laboratories (BIO) Gross Margin Growth (1y) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 128.00
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 448.00
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 60.00
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 305.00
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -6.00
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 391.00
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 153.00
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -4,158.00
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 69.00
10 Bio-Rad Laboratories 10.08 Bn 8.46 Bn 345.80 Mn 13.00

Historic Data

Download Data
DateValue
Jun 30, 2026 13.00
Mar 31, 2026 -2.00
Dec 31, 2025 -144.00
Sep 30, 2025 -219.00
Jun 30, 2025 -262.00
Mar 31, 2025 -108.00
Dec 31, 2024 -254.00
Sep 30, 2024 167.00
Jun 30, 2024 239.00
Mar 31, 2024 -19.00
Dec 31, 2023 -60.00
Sep 30, 2023 -162.00
Jun 30, 2023 -393.00
Mar 31, 2023 -396.00
Dec 31, 2022 -20.00
Sep 30, 2022 -370.00
Jun 30, 2022 113.00
Mar 31, 2022 240.00
Dec 31, 2021 -368.00
Sep 30, 2021 169.00